Preview – CDR-Life owned

Solid tumor TECHNOLOGY PROGRAM INDICATIONS DISCOVERY PRECLINICAL CLINICAL INTRACELLULAR ANTIGEN SPECIFIC T CELL ENGAGER SURFACE ANTIGEN SPECIFIC T CELL ENGAGER PARTNERED WITH BOEHRINGER INGELHEIM M-gager® CDR404 MAGEA4 CDR813 Cancer Testis Antigen Solid tumor CDR304 Dark Matter Antigen CDR505 Cancer Testis Antigen Fragment CDR101 BCMAxCD3xPD-L1 CDR202 Undisclosed Lung, bladder, head and neck cancer Solid tumor Solid tumor CDR208 Tumor Stroma Antigen Multiple Myeloma Multiple Degeneration Trispecific